VA

The deal, which will help develop personalized cancer treatments for veterans, marks the latest in a series of personalized medicine alliances for IBM.

The work will support the Million Veteran Program, which aims to study the link between genes and disease using a research cohort veterans and active military.

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

If the regional precision medicine program is successful, the VA might expand it for veterans around the country.

Personal Genome Diagnostics will supply its CancerSelect targeted gene panel to test veterans with newly diagnosed lung cancer.

NEW YORK (GenomeWeb) – The US Department of Veterans Affairs has awarded Bina Technologies a $1 million contract to conduct genomic analyses as part of the VA's Million Veteran Program, Bina said today.

NEW YORK (GenomeWeb) – Assurex Health today said that the US Department of Veterans Affairs has approved the firm's GeneSight Psychotropic test for use in VA facilities nationwide.

NEW YORK (GenomeWeb News) – Akesogen today announced the US Department of Veterans Affairs has awarded the company a five-year, $7.5 million contract to genotype samples from US military veterans as part of the Million Veteran Program.

NEW YORK (GenomeWeb News) – The US Department of Veterans Affairs has awarded startup clinical diagnostics laboratory Claritas Genomics a $9 million contract to sequence the exomes of veteran samples, Claritas, Life Technologies, and Lockheed Martin announced today.

Pages

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.